Stocks
Atara Biotherapeutics (ATRA) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -1 674% | -520.3% | -3 085% | -613.5% | ||||
| Changes by years, y/y, % | +1 154pp | -2 564pp | +35.8% | ||||||
Atara Biotherapeutics. EBITDA margin, %
Atara Biotherapeutics. EBITDA margin, changes, pp
Atara Biotherapeutics (ATRA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -6 119% | -7 161% | -3 144% | -1 225% | -91.8% | -613.5% | |
| Changes by years, y/y, % | -4 934pp | -7 004pp | -1 277pp | +32 956pp | +6 027pp | |||
| Changes by quarters, q/q, % | +28 062pp | -1 042pp | +4 017pp | +1 919pp | +1 133pp | |||
